preeloader
Contact Info
Ahmedabad, Gujarat, India business@primeservicescro.com
Image

Oncology Expertise

The team of Prime Services Research ensures excellence across all phases of clinical development, from first-in-human studies to large-scale pivotal trials and real-world evidence generation.

With experience spanning chemotherapy, immunotherapy, targeted therapy, radiotherapy, and supportive care products, we deliver strategies that align with global oncology standards while keeping patient safety, quality of life, and survival at the forefront.

Our comprehensive oncology research approach covers all therapeutic modalities and treatment combinations. We focus on delivering evidence that supports improved survival outcomes, enhanced quality of life, and meaningful patient experiences while ensuring compliance with international oncology research standards and regulatory requirements.

Our Deliveries

  • Comprehensive Clinical Trials Specialized design and execution for oncology drugs, biologics, devices, and combination therapies
  • Regulatory Excellence Expertise in oncology-specific regulatory pathways, orphan drug approvals, and accelerated access programs
  • Patient-Centric Research Emphasis on quality of life, symptom management, and survivorship alongside clinical efficacy
  • Outcome-Driven Insights Generation of meaningful endpoints, including progression-free survival, overall survival, and patient-reported outcomes

Our Capabilities

  • Clinical Trial Services Study Design: Tailored oncology protocols with disease-specific endpoints (tumor response rates, survival metrics, biomarkers). Patient Recruitment: Leveraging oncology networks, registries, and advocacy groups to ensure diverse patient participation. Site Management: Partnering with leading cancer centers and hospitals for high-quality data collection and adherence to protocols. Data Collection & Analysis: Incorporating imaging, molecular biomarkers, genomic profiling, and advanced statistical modeling.
  • Regulatory Compliance GCP Alignment: Conducting oncology trials under the highest ethical and clinical standards. Regulatory Submissions: Preparing INDs, NDAs, BLAs, and global oncology dossiers with alignment to FDA, EMA, and other regional agencies.
  • Patient-Centric Approach Quality of Life Measures: Integrating patient-reported outcomes on fatigue, pain, and treatment burden. Supportive Care: Designing trials that assess not only survival but also the patient's overall treatment experience and well-being.
  • Research Insights Publications: Peer-reviewed articles, case studies, and white papers on breakthrough therapies and oncology innovations. Access to Journals: Continuous updates from global oncology journals and cancer research societies.